We found that our NK-AML subgroup was split into two distinctive clusters based on DNA methylation, and that mutations in WT1, FLT3, and CEBPA were overrepresented in one of the clusters (Cluster B), while the other cluster contained few mutations (Cluster A). Here, CEBPA is linked to acute myeloid leukemia.